BioScrip, Inc. (NASDAQ:BIOS)
CAPS Rating:
The Company provides pharmaceutical and pharmacy benefit management services.
Growing the love for investing
The Company provides pharmaceutical and pharmacy benefit management services.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
CHS acquisition to assist with revenue and earnings growth. Fairly priced today, but has potential to outperform once all acquisition operational issues are resolved.